Pfizer Clinches Deal for Obesity Drug Developer Metsea
Digest more
WASHINGTON — Pfizer Inc., the world's largest drug maker, will pay a record $2.3 billion civil and criminal penalty over unlawful prescription-drug promotions. Announcing the settlement Wednesday, ...
Pfizer's agreement to buy Metsera just adds to the 83 healthcare deals counted by Goldman Sachs that were above $100 million ...
President Donald Trump announced on Tuesday a drug pricing deal with Pfizer that will see the pharmaceutical giant lower the cost of its medications for Americans. Trump made the announcement from ...
Pfizer and Flagship Pioneering are continuing to fill in the blanks for their 10-program partnership, unveiling agreements with two more Flagship-founded biotechs to chase targets in obesity and ...
Pfizer signed a deal with the White House to help Americans pay lower prices for prescription drugs. This agreement removes the uncertainty hanging over Pfizer's head related to the Trump ...
Six months after scoring FDA approval for hemophilia B gene therapy Beqvez, Pfizer has earned a nod from the U.S. regulator for another of its products in the indication. On Friday, the FDA signed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback